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The crystal structure of Staphylococcus aureus cytidine monophosphate kinase
(CMK) in complex with cytidine 50-monophosphate (CMP) has been
determined at 2.3 A ˚ resolution. The active site reveals novel features when
compared with two orthologues of known structure. Compared with the
Streptococcus pneumoniae CMK solution structure of the enzyme alone,
S. aureus CMK adopts a more closed conformation, with the NMP-binding
domain rotating by  16  towards the central pocket of the molecule, thereby
assembling the active site. Comparing Escherichia coli and S. aureus CMK–CMP
complex structures reveals differences within the active site, including a
previously unreported indirect interaction of CMP with Asp33, the replacement
of a serine residue involved in the binding of CDP by Ala12 in S. aureus CMK
and an additional sulfate ion in the E. coli CMK active site. The detailed
understanding of the stereochemistry of CMP binding to CMK will assist in the
design of novel inhibitors of the enzyme. Inhibitors are required to treat the
widespread hospital infection methicillin-resistant S. aureus (MRSA), currently
a major public health concern.
1. Introduction
Staphylococcus aureus has long been recognized as a major cause of
hospital-acquired infection. It has become a considerable public
health threat as a result of the increased incidence of drug resistance
in this organism (Boyce et al., 2005). In 1947, S. aureus was the ﬁrst
bacterium in which penicillin resistance was found. Methicillin then
became the antibiotic of choice, but over the past decade methicillin-
resistant S. aureus has become endemic in hospitals worldwide
(Boyce et al., 2005). This drug resistance has left antibiotics such as
vancomycin as one of the few effective agents to treat serious MRSA
infections. However, vancomycin-resistant S. aureus (VRSA) has
now been identiﬁed: the ﬁrst example was isolated in Japan in 1997
(Hiramatsu et al., 1997). It is clear that new drug therapies are
required to treat S. aureus related infections.
Cytidine monophosphate kinase is a member of the nucleoside
monophosphate kinase (NMK) family (Leipe et al., 2003). CMK has
been suggested to be essential for the growth of two Gram-positive
bacteria: Bacillus subtilis (Sorokin et al., 1995) and Streptococcus
pneumoniae (Yu et al., 2003). The enzyme plays a crucial role in the
biosynthesis of nucleotide precursors. Bacterial CMKs catalyze
phosphoryl transfer from ATP speciﬁcally to CMP or dCMP. In
eukaryotes, UMP/CMP kinase catalyzes the conversion of UMP and
CMP to their diphosphate forms (Segura-Pena et al., 2004). The
bacterial CMKs differ from other NMP kinases by possessing a
40-residue insert in the NMP-binding domains and short LID
domains (Briozzo et al., 1998). These differences could be exploited in
the development of safe novel antibacterials targeted speciﬁcally
towards S. aureus CMK and/or closely related bacterial orthologues
such as S. pneumoniae CMK (Yu et al., 2003) and B. subtilis CMK
(Sorokin et al., 1995).
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in complex with CMP at a resolution of 2.3 A ˚ .T h eSaCMK model
reveals novel features of the active site when compared with two
other orthologues of known structure. Comparison with the S.
pneumoniae CMK (SpCMK) solution structure (Yu et al., 2003)
shows that SaCMK adopts a more closed conformation with the
NMP-binding domain rotating by  16  towards the central cavity of
the molecule, thus assembling the active site. When comparing the
SaCMK–CMP structure with Escherichia coli CMK (EcCMK) also in
complex with CMP (Bertrand et al., 2002), we observe a previously
unreported indirect interaction of Asp33 with CMP. There is an
additional sulfate ion within the EcCMK substrate-binding site and
Ala12 in SaCMK replaces a serine residue (14) in the corresponding
position in EcCMK. This serine is known to play an important role in
the binding of CDP (Briozzo et al., 1998).
2. Experimental methods
2.1. Preparation and purification
The S. aureus CMK-encoding sequence was PCR-ampliﬁed and
subcloned into the E. coli expression vector pET15b to yield the
recombinant plasmid pMUT74. The plasmid was sequenced to ensure
that no spurious mutations had been introduced during the PCR
reaction. The plasmid pMUT53 was transformed into the E. coli
expression strain Codon
+ and transformants were selected on Luria
agar supplemented with 100 mgm l
 1 ampicillin and 35 mgm l
 1
chloramphenicol. Cells transformed with pMUT74 were grown in an
orbital incubator at 310 K in 500 ml volumes of Luria broth supple-
mented with 100 mgm l
 1 ampicillin and 35 mgm l
 1 chloramphenicol
until an attenuance at 550 nm of 0.6.At this point, IPTG was added to
a ﬁnal concentration of 0.2 mg ml
 1 and the cultures were incubated
for a further 5 h at 310 K. Cells were then harvested by centrifugation
and stored at 255 K until required.
The cells were sonicated in 50 mM potassium phosphate pH 7.2,
1m M DTT, 1 mM benzamidine whilst stirring on an ice–water
mixture. All subsequent steps were carried out at 277 K and 10 ml
column fractions were collected. Following centrifugation, the cell-
free supernatant was chromatographed on a 100 ml IMAC column
charged to one-third capacity with Zn
2+, equilibrated with 50 mM
potassium phosphate pH 7.2, 1 mM DTTand then eluted with a 0.0–
0.3 M imidazole gradient in 50 mM potassium phosphate pH 7.2,
1m M DTT. Fractions containing the N-terminal His-tagged SaCMK
were identiﬁed by SDS–PAGE, pooled appropriately and dialysed
against 50 mM potassium phosphate pH 7.2, 1 mM DTT. After
dialysis, the pool was ﬁltered through a 0.45 mm ﬁlter and loaded onto
a hydroxyapatite column equilibrated with 50 mM potassium
phosphate pH 7.2, 1 mM DTT; the SaCMK eluted in the column
ﬂowthrough. Fractions containing SaCMK were again identiﬁed by
SDS–PAGE and pooled appropriately. This procedure yielded
approximately 480 mg of puriﬁed SaCMK from 25 g of cell paste.
2.2. Crystallization
Prior to crystallization, SaCMK was concentrated and buffer-
exchanged for 20 mM Tris–HCl pH 7.4, 40 mM KCl and 0.1% sodium
azide using Vivascience Vivaspin centrifugal concentrators. Pooled
concentrates were then ﬁltered through Amersham NAP 25 desalting
columns and re-concentrated to 40 mg ml
 1.
SaCMK was initially screened in crystallization trials with a total of
 1440 droplets [with standard conditions consisting of Hampton,
Wizard and Emerald kits for two different ligand complexes; one with
adenosine 50-( -thio)triphosphate (ATP S) and CMP and the other
with CMP alone]. The crystallization system developed at the Oxford
Protein Production Facility was used for the initial screening phase
(Walter et al., 2005). A Cartesian Technologies pipetting robot was
used to set up nano-crystallizations consisting of 100 nl protein
solution and 100 nl reservoir solution mixed as sitting drops in 96-well
Greiner plates. Crystallization plates were placed in a TAP Home-
base storage vault maintained at 295 K and imaged via a Veeco
visualization system (Walter et al., 2005). Larger scale droplets were
set up to optimize initial hits. The best diffracting crystals grew when
a protein complex consisting of 15 mg ml
 1 SaCMK, 2.5 mM CMP
and 2.5 mM ATP S was used with 1.6 M ammonium sulfate, 0.1 M
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Figure 1
A crystal of S. aureus CMK grown in a sitting drop by vapour diffusion. The crystal
is approximately 0.2 mm in length. The crystals belong to the hexagonal space
group P64.
Table 1
Statistics for crystallographic structure determination.
Values in parentheses are for the outer resolution shell.
Beamline ID14EH1, ESRF
Wavelength (A ˚ ) 0.9340
Space group P64
Unit-cell parameters (A ˚ ) a = b = 157.89, c = 76.23
Resolution range (A ˚ ) 30.0–2.3 (2.38–2.30)
Observations 667447 (33099)
Unique reﬂections 48287 (4810)
Average redundancy 13.8 (6.9)
Completeness (%) 100.0 (100.0)
I/ (I) 22.7 (3.4)
Rmerge† 0.094 (0.597)
Reﬁnement statistics
Resolution range (A ˚ ) 30.0–2.3
Total No. of reﬂections 48287
No. of working reﬂections 45687
No. of test reﬂections 2420
R factor‡ 0.211
Rworking 0.214
Rfree 0.261
No. of atoms
Protein 5091
Water 334
Others 90
R.m.s. bond-length deviation (A ˚ ) 0.0083
R.m.s. bond-angle deviation ( ) 1.27
Mean B factor (A ˚ 2)
Main chain 40
Side chain 48
Waters 43
Ligands§ 38
R.m.s. backbone B-factor deviation} 4.6
† Rmerge =
P
jI  h Iij=
P
hIi.‡ R factor =
P
jFo   Fcj=
P
Fo. § CMP, SO2 
4 and
PEG. } R.m.s. deviation between B factors for bonded main-chain atoms.HEPES pH 7.8, 2% PEG 200 as the precipitant. Crystals grew to a
maximal length of 0.3–0.8 mm within 6 d (Fig. 1).
2.3. Data collection and structure determination
Crystals of SaCMK were ﬂash-cooled to 100 K (using 100%
tacsimate as a cryoprotectant) and diffraction data were collected at
beamline ID14EH1, ESRF (Grenoble, France). Indexing, integration
and merging of data were carried out with the HKL (v.1.96.1) suite of
programs (Otwinowski & Minor, 1997). Data-collection and reﬁne-
ment statistics are shown in Table 1.
A molecular-replacement solution was found with the CNS suite of
programs (Bru ¨nger et al., 1998) using the modiﬁed PDB entry 1kdo
(Bertrand et al., 2002), i.e. E. coli CMK in complex with CMP, as a
search model. The NMP-binding, LID and CORE domains (Briozzo
et al., 1998) were treated as separate ‘rigid bodies’ during molecular
replacement. The initial model underwent two rounds of rigid-body
reﬁnement followed by simulated annealing. Iterative cycles of
conjugate-gradient minimization with subsequent individual B-factor
reﬁnement in CNS and manual model rebuilding with O (Jones et al.,
1991) were then run.
Structural superpositions of the CMKorthologues were performed
with SHP (Stuart et al., 1979).
3. Results and discussion
3.1. Overall and domain structure
There are three SaCMK molecules within the asymmetric unit,
containing residues 3–218 of the protein. When compared with
molecule A, both molecules B and C have a root-mean-square
deviation (r.m.s.d.) of just 0.1 A ˚ for the superposition of 216 pairs of
C
  atoms. Therefore, the three protein molecules are essentially
identical in structure. The N-terminal methionine and lysine residues
are not observed and the C-terminal lysine appears to be disordered.
Electron-density maps show unambiguous Fo   Fc density for CMP
in all three molecules of the asymmetric unit; these were added to the
model during the later stages of reﬁnement (Fig. 2a). In addition, the
asymmetric unit contains three SO2 
4 ions, one PEG molecule and 334
water molecules. The SaCMK model was evaluated using
PROCHECK (Laskowski et al., 1993), which indicated that 90% of
the ﬁnal model’s residues lie within the most favoured regions of a
Ramachandran plot and 10% within the additionally allowed regions
(Ramachandran et al., 1963).
The overall structure of the SaCMK–CMP complex is illustrated in
Fig. 3. The secondary-structure elements of SaCMK include nine
 -helices and eight  -strands. Until recently, all members of the NMP
kinase family for which three-dimensional structures were known
consisted of three domains (Yan & Tsai, 1999). This is no longer true
as the recently published structures of UMP kinases from E. coli
(Briozzo et al., 2005) and Pyrococcus furiosus (Marco-Marin et al.,
2005) are not comprised of three domains. However, the three clas-
sical domains of NMP kinases are found in SaCMK. The parallel
 -sheet consisting of strands  1– 2 and  6– 8 ﬂanked by  -helices
 1,  6 and  9 make up the CORE domain that contains a highly
conserved phosphate-binding loop (P-loop; residues 10–16). The
small LID domain, containing residues 155–168 (i.e. including the
C-terminal and N-terminal halves of  7 and  8, respectively), closes
over the phosphate donor and bears functionally essential residues,
whilst the NMP-binding domain (residues 33–100) comprises
 -helices  2– 5, the antiparallel  -sheet  3– 5 and the intervening
loop regions. This latter domain is responsible for the recognition and
binding of the CMP or dCMP substrate (Bertrand et al., 2002). The
three domains pack together to form a central pocket for substrate-
binding and enzyme catalysis. In order to prevent unwanted ATP
hydrolysis in the absence of substrate, the kinases disassemble their
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Figure 2
(a) Stereo diagram showing the Fo   Fc annealed electron-density map with the
CMP molecule omitted, contoured at 5 . The ﬁgure was prepared using CNS
(Bru ¨nger et al., 1998), BOBSCRIPT (Esnouf, 1999) and RASTER3D (Merritt &
Bacon, 1997). (b) Atom nomenclature for CMP. The ﬁgure, showing a stick
representation of CMP, was prepared using PyMOL (DeLano, 2002).
Figure 3
A cartoon representation of the overall structure of the SaCMK–CMP complex.
The protein structure is coloured according to secondary-structure element:
 -helices are coloured red,  -strands are yellow and loop regions are green. The
ﬁgure was prepared using PyMOL.active site. On the binding of substrate, an induced-ﬁt movement
occurs, repositioning the catalytically important residues (Schulz et
al., 1990; Krell et al., 2001; Bertrand et al., 2002).
Compared with other NMP kinases, CMKs have a large insert in
the NMP-binding domain (Briozzo et al., 1998). In SaCMK, the NMP-
binding insert is from Leu57 to Tyr97. The insert contains  -helices
 3– 5 and the antiparallel  -sheet  3– 5. The NMP-binding insert is
thought to play a role in dCMP phosphorylation (Bertrand et al.,
2002).
3.2. The SaCMK NMP-binding site
The cytosine base of CMP binds near the ends of  2 and  6, with
the  -phosphate group pointing towards the P-loop located between
 1 and  1. The P-loop has a typical mononucleotide-binding motif,
Gly(10)-X-X-Ala-X-Gly-Lys(16). This loop forms a large anion hole
in which a sulfate ion is bound. This sulfate ion is observed in a similar
position in several other NMP kinase structures, such as E. coli CMK
(Briozzo et al., 1998; Bertrand et al., 2002), yeast GMK (Stehle &
Schulz, 1992) and bovine AMK (Diederichs & Schulz, 1991). The
position of the SO2 
4 ion corresponds to the  -phosphate group of
ATP (Diederichs & Schulz, 1991).
The NMP-binding pocket is characterized by a generally hydro-
phobic surface together with a number of charged residues projecting
into the pocket. The lipophilic part of the the cavity is formed by the
highly conserved CMK residues Gly35 and Gly125 [identiﬁed using
BLAST (Altschul et al., 1990), results not shown] and the semi-
conserved residues Val95 and Ala99, which in some orthologues are
replaced by an alanine and a serine, respectively. Ser96, part of the
NMP-binding insert, forms a hydrogen bond with Asp180 and is
thought to play a critical role in the phosphorylation of dCMP
(Bertrand et al., 2002).
The CMP molecule makes a number of key interactions with
several highly conserved residues projecting into the NMP-binding
pocket, namely Asp33, Tyr38, Arg39, Arg105, Arg126, Asp127,
Arg176, Asp180 and Arg183 and the semi-conserved Thr34 (Fig. 4).
These interactions include (i) Arg39 and Arg126 hydrogen bonding
with the  -phosphate of the CMP, (ii) Arg105 interacting with both
the cytosine moiety and  -phosphate, (iii) the aromatic ring of Tyr38
stacking against the cytosine ring, (iv) Thr34, Asp127 and Arg183
hydrogen bonding to the cytosine, (v) Arg176 and Asp180 hydrogen
bonding with the hydroxyl groups of the ribose ring and (vi) the
previously unreported indirect interaction of Asp33 with the
 -phosphate of CMP by forming 2.8 and 3.4 A ˚ hydrogen bonds with
the ordered water molecules W4 and W2 through its OD1 and OD2
hydroxyl groups, respectively. A detailed list of contacts made
between the CMP molecule and SaCMK can be found in Table 2.
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Figure 4
Stereo diagram showing the superposition of some of the CMP-interacting residues and ordered water molecules of SaCMK–CMP (coloured by element) and E. coli CMK–
CMP (blue) complexes. Residue numbers in parentheses are the corresponding residues in the E. coli orthologue. The hydrogen-bonding network is represented as grey
dashed lines. A full list of the interactions made between SaCMK and CMP can be found in Table 2. The ﬁgure was prepared using BOBSCRIPT and RASTER3D.
Table 2
Interactions between SaCMK and CMP (molecule A).
The distances were determined using the CONTACT program (Collaborative
Computational Project, Number 4, 1994) with 0–3.6 A ˚ distance limits.
CMP atom SaCMK/water atom Distance (A ˚ )
C2 Arg105 NH1 3.5
Arg105 NH2 3.4
C4 Thr34 OG1 3.4
Tyr38 CE1 3.6
Arg126 N 3.2
C5 Thr34 OG1 3.2
Wat1 O 3.5
C6 Tyr38 CD1 3.5
C2* Asp180 OD1 3.4
Asp180 OD2 3.3
C3* Asp180 OD2 3.4
C5* Arg176 NH2 3.5
N1 Tyr38 CD1 3.5
N3 Tyr38 CE1 3.4
Arg105 NH2 3.0
Arg126 CB 3.5
N4 Thr34 OG1 2.9
Gly125 C 3.5
Gly125 CA 3.1
Arg126 N 2.9
Asp127 OD1 3.2
O2 Arg105 CZ 3.3
Arg105 NH1 2.7
Arg105 NH2 3.1
Arg183 CZ 3.2
Arg183 NH1 2.8
Arg183 NH2 2.8
O2* Ser96 CA 3.6
Asp180 CG 3.3
Asp180 OD1 2.7
Asp180 OD2 3.3
O3* Arg176 NE 3.4
Arg176 NH2 3.0
Asp180 OD2 2.7
Wat3 O 3.6
O1P Arg126 NH1 3.3
Arg126 NH2 3.3
Wat1 O 3.3
Wat2 O 2.8
O2P Arg39 CZ 3.5
Arg39 NE 2.8
Arg39 NH2 3.4
Wat4 O 2.7
O3P Arg39 NH2 3.1
Arg126 NH2 3.6
Arg176 NH2 2.5
Wat5 O 2.8All of the interactions described above serve to position and
orientate the O3P hydroxyl of the CMP molecule ready for nucleo-
philic attack by the  -phosphate of ATP.
3.3. Structural comparison of S. aureus CMK with two orthologues
The three-dimensional structures of two other bacterial CMKs
have been determined. These are (i) the solution structure of
S. pneumoniae CMK (Yu et al., 2003) and (ii) the crystal structure of
unliganded E. coli CMK and in a complex with CDP (Briozzo et al.,
1998), as well as in complex with CMP, dCMP, 20,30-dideoxy-CMP
(ddCMP) and cytosine  -d-arabinofuranoside 50-monophosphate
(AraCMP) (Bertrand et al., 2002).
The S. aureus and S. pneumoniae CMKs share a sequence identity
of 51% (Fig. 5a). The structures superimpose with an r.m.s.d. of 1.9 A ˚
for 141 pairs of C
  atoms. The SaCMK and SpCMK structures closely
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Figure 5
(a) An alignment of the amino-acid sequence of SaCMK with those of CMK from E. coli (EcCMK) and S. pneumoniae (SpCMK), drawn with ESPRIPT (Gouet et al., 1999).
Residues are boxed according to an alignment made with ClustalW (Thompson et al., 1994; SwissProt IDs P63807, Q97PK6 and P0A6I0 for SaCMK, SpCMK and EcCMK
sequences, respectively). Residues that are strictly conserved have a red background, residues that are well conserved are indicated by red lettering and the remainder are in
black. The secondary-structure elements of SaCMK are presented at the top:  -helices by squiggles and  -strands by arrows. The positions of the P-loop, the NMP-binding
domain and the LID domain of SaCMK are indicated below the alignment. (b) A ribbon representation showing the superposition of the SaCMK–CMP (coloured red),
EcCMK–CMP (blue) and apo SpCMK (green) complexes. The ﬁgure was prepared using PyMOL.resemble one another. However, whereas the LID domains adopt
similar conformations, the NMP-binding domain of the apo SpCMK
adopts a more ‘open’ conformation compared with the corresponding
domain in the SaCMK–CMP structure. Thus, the SaCMK NMP-
binding domain, which comprises residues responsible for the
recognition and binding of CMP, is rotated by  16  towards the
central pocket of the molecule, thereby assembling the active site
(Fig. 5b). This movement is a consequence of the binding of CMP.
The CMKs from S. aureus and E. coli share a sequence identity of
38% (Fig. 5a). Compared with both EcCMK and SpCMK, SaCMK
has a two-residue deletion in  -strand  1 and a four-residue deletion
in the loop region between  -helices  2 and  3. Also, SaCMK has a
single aspartate residue insertion at position 70 compared with
EcCMK. As expected, the SaCMK–CMP structure most closely
resembles the EcCMK–CMP complex structure, with an r.m.s.d. of
1.4 A ˚ for the superposition of 198 pairs of C
  atoms. The CORE, LID
and NMP-binding domains of the E. coli and S. aureus CMK
orthologues all adopt very similar conformations. Indeed, the archi-
tecture of the NMP-binding site is well conserved (Fig. 4). The
signiﬁcant differences between the SaCMK and EcCMK structures
within the active-site cavity are as follows. (i) Thr34 is conservatively
substituted for a serine residue in EcCMK. However, the same
hydrogen-bonding interaction with the N4 amine group of the cyto-
sine moiety of CMP is maintained by the threonine OG1 and serine
OG hydroxyl groups of S. aureus and E. coli CMKs, respectively. (ii)
There is an additional sulfate ion in the EcCMK substrate-binding
site. (iii) Ala12 in SaCMK is replaced by a serine (Ser14) in EcCMK.
Most orthologues have an alanine or glycine residue at this position,
while some have a serine (identiﬁed using BLAST; results not
shown). In the EcCMK–CDP crystal structure it was shown that the
hydroxyl group of Ser14 forms a strong 2.6 A ˚ hydrogen bond with the
 -phosphate of CDP (Briozzo et al., 1998). This suggests that CDP
may bind more tightly to EcCMK than SaCMK.
In conclusion, knowledge of the detailed stereochemistry of
substrate binding to CMK is clearly important in the use of structure-
based approaches to design novel inhibitors targeting the CMP-
binding site. Design of such inhibitors is needed as part of efforts to
develop new antibacterial drugs for treating MRSA infections, which
currently cause many deaths in hospitalized patients and are thus a
major public health concern.
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